Is NovaBridge Biosciences overvalued?

NovaBridge Biosciences (NBP) — key valuation metrics and fundamentals.

No verdict

Price

$1.96

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$225.9M

Dividend yield

0.0%

Return on equity

-0.6%

Sector

Healthcare

Fair value compares NBP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks